NEWS and OPINIONS
Cell-Based Therapies Show Promise for Seriously Ill Patients with COVID-19
Federal Funding for Large-Scale, Randomized, Controlled Trials is Needed to Confirm Results and Help Bring Safe and Effective Treatments to Patients in Need Washington, DC (March 24, 2021) – A new report released by Alliance for Cell Therapy Now, an independent,...
Antioxidant-primed stem cells show promise in repairing bone damaged by radiation
Durham, NC – The standard of treatment for bone tumors is often two-fold: surgery to remove the cancerous section followed by raadiation therapy to ensure all the cancerous cells have been killed off. This is an effective way to defeat bone tumors; however, it often...
Longeveron’s Lomecel-B™ Approved by FDA for Compassionate Use for the Treatment of Child with Hypoplastic Left Heart Syndrome (HLHS)
MIAMI, March 11, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, announced today that the U.S. Food...
Stem cells derived from fat show promise as a treatment for mass radiation exposure
Durham, NC – Nuclear power offers an efficient, reliable way to provide energy to large populations – as long as all goes well. Accidents involving nuclear reactors such as those that took place in 1986 at Chernobyl and at Fukushima Daiichi after the March 2011...
Good Worldwide Launches Leaps.org to Rebuild Public Trust in Science and Journalism
Non-profit Editorial Platform Fosters Renewed Enthusiasm for Scientific Progress March 15, 2021 – LeapsMag, the award-winning online magazine created to encourage public discussion about scientific innovation, re-emerges today as Leaps.org, a non- profit media...
Study provides evidence that bone marrow cell injections help heal the brain after stroke
Summary: Longitudinal imaging study provides evidence in patients that autologous bone marrow cells may lead to a reduction in white matter injury compared with stroke patients who did not receive bone marrow cells. Durham, NC – Results of a clinical trial released...
Phase I clinical trial shows promise of adipose-derived stem cells in treating lymphedema
Results of a phase I clinical trial released in STEM CELLS Translational Medicine shows there is a strong possibility that stem cells may alleviate lymphedema, a chronic debilitating condition affecting up to one in three women treated for breast cancer. Durham, NC –...
HCP Busted for Selling Fake Stem Cell Therapy
—Assistant physician and Missouri state legislator indicted for wire fraud, other crimes by Kristina Fiore, Director of Enterprise & Investigative Reporting, MedPage Today February 4, 2021 - A Missouri state lawmaker and medical professional was indicted by a...
New institute to leverage experts to advance regenerative medicine
JANUARY 19, 2021 —UTSA has launched a collaborative research institute that will benefit people suffering from a variety of vascular and other medical issues. The lnstitute of Regenerative Medicine will provide a unique resource and collection of research and...
Karīna Narbute’s Research in Extracellular Vesicles Earns Her Young Investigator Award
Durham, NC – Karīna Narbute, Ph.D. is the latest recipient of STEM CELLS Translational Medicine’s Young Investigator Award. The award fosters advancements in the field of stem cells and regenerative medicine by honoring a young researcher who is the principal author...
Retinal cell transplant clears experimental hurdle toward treating blindness
International Society for Stem Cell Research Retinal cells derived from adult human eye stem cells survived when transplanted into the eyes of monkeys, an important early step in the validation of this approach for treating blindness, according to a study by Liu, et...
Mid-term clinical trial results show similar outcomes in two promising cell therapies for CLI
Durham, NC – Mid-term results of the first clinical trial designed specifically to evaluate the safety and effectiveness of two cell therapies that are showing early promise in treating angiitis-induced critical limb ischemia were released today in STEM CELLS...